Search

everythinglearnresearchcommunity

for

Search:↓

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Scalp itching is common and hard to diagnose due to the complex nerve structure of the scalp.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

Different methods of preparing Platelet-Rich Plasma (PRP) can affect wound healing and hair regrowth in plastic surgery. Using a kit with specific standards helps isolate PRP that meets quality criteria. Non-Activated PRP and Activated PRP have varying effects depending on the tissue and condition treated. For hair regrowth, Non-Activated PRP increased hair density more than Activated PRP. Both treatments improved various aspects of scalp health.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Frequent use of chemical hair relaxants is linked to increased scarring hair loss in Nigerian women.

A hair-straightening product caused widespread hair loss and scalp injuries, mainly affecting African American women.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Properly formulated large molecules can reach active levels at the hair bulb.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Trichoscopy is a useful tool for diagnosing different hair and scalp diseases without surgery.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Healthy scalp reduces hair loss by managing oxidative stress.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Cedrol from Platycladus orientalis leaves may promote hair growth effectively, especially in female mice.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

Itchy scalp is common, linked to various conditions, and hard to treat effectively.

Scalp cooling effectively reduces hair loss from chemotherapy.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Oral minoxidil helps hair growth, is cost-effective, and mostly well-tolerated.

People with HIV and low T cell counts have more hair and scalp problems.

Erosive pustular dermatosis is a rare skin disease that's hard to treat and affects the scalp or legs.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.